WAM
DMII

Wolverine Asset Management’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Wolverine Asset Management’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
1,855,222
+59,931
+3% +$602K 0.16% 121
2026
Q1 		$17.9M Buy
1,795,291
+732,518
+69% +$7.3M 0.17% 129
2025
Q4 		$10.5M Buy
+1,062,773
New +$10.5M 0.08% 237

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Wolverine Asset Management's DMII Position: Q2 2026 in Review

Wolverine Asset Management increased its Drugs Made In America Acquisition II Corp (DMII) stake by 3.3% in Q2 2026, buying an estimated $602K and bringing the position to 1,855,222 shares worth $18.7M. The position accounts for 0.16% of the portfolio, ranked #121.

Wolverine Asset Management first reported a position in DMII in Q4 2025 and has held it in 3 quarters since. 69 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • Wolverine Asset Management held 1,855,222 shares of Drugs Made In America Acquisition II Corp worth $18.7M as of Q2 2026.
  • Wolverine Asset Management bought 59,931 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $602K.
  • Drugs Made In America Acquisition II Corp made up 0.16% of Wolverine Asset Management's portfolio in Q2 2026, its #121 holding.
  • Wolverine Asset Management first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 3 quarters since.
  • 69 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.